US Lawmakers Scale Back China Chip Bill, Removing Curbs on Lam Research's Etch Tools
LRCX has more than doubled off its 52-week low of $61.14 on light trading volume (0.1× avg).
Summary
U.S. lawmakers have scaled back the proposed 'MATCH Act' aimed at restricting Chinese chipmaking, a significant positive development for Lam Research. The revised bill specifically removes countrywide curbs on cryogenic etch tools, a key product manufactured by Lam Research. This legislative adjustment alleviates a material regulatory risk that had caused 'alarm' within the industry, potentially preserving Lam Research's access to the crucial Chinese market for these tools. While the bill still includes some restrictions on other firms and requires licenses for servicing equipment, the removal of direct curbs on LRCX's products is a clear benefit. Investors should monitor the upcoming vote in the House Foreign Affairs Committee next Wednesday as the bill progresses through the legislative process.
At the time of this announcement, LRCX was trading at $263.12 on NASDAQ in the Technology sector, with a market capitalization of approximately $328.6B. The 52-week trading range was $61.14 to $273.50. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Reuters.